Turkey, Istanbul
Cuneyt Turkmen
Xofigo Radium-223 therapy is a targeted alpha treatment for prostate cancer bone metastases available at Memorial Şişli Hospital in Istanbul, Turkey. One course may cost around $18,000 USD, with Prof. Cuneyt Turkmen leading the treatment - a nuclear medicine specialist with 27 years of experience and 900+ procedures performed.
About the Treatment
Xofigo Radium-223 is designed specifically for castration-resistant prostate cancer with bone metastases. It delivers alpha radiation directly to bone lesions while minimizing exposure to healthy tissue. Patients typically receive 4 treatment courses at 6-8 week intervals.
What's Included
- Radium-223 radiopharmaceutical treatment per course
- 1 day hospitalization in nuclear medicine department
- Required laboratory tests
Doctor Profile
Prof. Cuneyt Turkmen specializes in nuclear medicine and oncology with 27 years of practice. He has performed over 900 nuclear medicine procedures and published 86 scientific papers. As a member of the European Association of Nuclear Medicine, he follows international treatment protocols.
Clinic Advantages
Memorial Şişli Hospital holds JCI accreditation and LEED Platinum certification. The facility maintains a 4.6 patient rating from 320+ reviews. Their nuclear medicine department is equipped for precise radiopharmaceutical administration and monitoring.
Patients considering this treatment should schedule a consultation with Prof. Turkmen to discuss eligibility and create a personalized treatment plan.